Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
Phantom-Mobility-Based Prosthesis Control in Transhumeral Amputees Without Surgical Reinnervation: A Preliminary Study.

Frontiers in bioengineering and biotechnology

Jarrassé N, de Montalivet E, Richer F, Nicol C, Touillet A, Martinet N, Paysant J, de Graaf JB.
PMID: 30555823
Front Bioeng Biotechnol. 2018 Nov 29;6:164. doi: 10.3389/fbioe.2018.00164. eCollection 2018.

Transhumeral amputees face substantial difficulties in efficiently controlling their prosthetic limb, leading to a high rate of rejection of these devices. Actual myoelectric control approaches make their use slow, sequential and unnatural, especially for these patients with a high...

Cite
Jarrassé N, de Montalivet E, Richer F, et al. Phantom-Mobility-Based Prosthesis Control in Transhumeral Amputees Without Surgical Reinnervation: A Preliminary Study. Front Bioeng Biotechnol. 2018;6:164doi: 10.3389/fbioe.2018.00164.
Jarrassé, N., de Montalivet, E., Richer, F., Nicol, C., Touillet, A., Martinet, N., Paysant, J., & de Graaf, J. B. (2018). Phantom-Mobility-Based Prosthesis Control in Transhumeral Amputees Without Surgical Reinnervation: A Preliminary Study. Frontiers in bioengineering and biotechnology, 6164. https://doi.org/10.3389/fbioe.2018.00164
Jarrassé, Nathanaël, et al. "Phantom-Mobility-Based Prosthesis Control in Transhumeral Amputees Without Surgical Reinnervation: A Preliminary Study." Frontiers in bioengineering and biotechnology vol. 6 (2018): 164. doi: https://doi.org/10.3389/fbioe.2018.00164
Jarrassé N, de Montalivet E, Richer F, Nicol C, Touillet A, Martinet N, Paysant J, de Graaf JB. Phantom-Mobility-Based Prosthesis Control in Transhumeral Amputees Without Surgical Reinnervation: A Preliminary Study. Front Bioeng Biotechnol. 2018 Nov 29;6:164. doi: 10.3389/fbioe.2018.00164. eCollection 2018. PMID: 30555823; PMCID: PMC6282038.
Copy Download .nbib Format: NLM
Ionic and non-ionic intravenous X-ray contrast media: antibacterial agents?.

Acta radiologica (Stockholm, Sweden : 1987)

Mosler F, Richter JK, Schindewolf M, Mertineit N, Tengg-Kobligk HV, Heverhagen JT, Nöldge G.
PMID: 34056917
Acta Radiol. 2021 May 30;2841851211019804. doi: 10.1177/02841851211019804. Epub 2021 May 30.

X-ray contrast media have been reported to have inhibitory effects on bacterial growth. Despite its potentially beneficial effect on patients, these features of contrast media have received relatively little attention in the medical literature in the past decades. The...

Cite
Mosler F, Richter JK, Schindewolf M, et al. Ionic and non-ionic intravenous X-ray contrast media: antibacterial agents?. Acta Radiol. 2021;2841851211019804doi: 10.1177/02841851211019804.
Mosler, F., Richter, J. K., Schindewolf, M., Mertineit, N., Tengg-Kobligk, H. V., Heverhagen, J. T., & Nöldge, G. (2021). Ionic and non-ionic intravenous X-ray contrast media: antibacterial agents?. Acta radiologica (Stockholm, Sweden : 1987), 2841851211019804. https://doi.org/10.1177/02841851211019804
Mosler, Frank, et al. "Ionic and non-ionic intravenous X-ray contrast media: antibacterial agents?." Acta radiologica (Stockholm, Sweden : 1987) vol. (2021): 2841851211019804. doi: https://doi.org/10.1177/02841851211019804
Mosler F, Richter JK, Schindewolf M, Mertineit N, Tengg-Kobligk HV, Heverhagen JT, Nöldge G. Ionic and non-ionic intravenous X-ray contrast media: antibacterial agents?. Acta Radiol. 2021 May 30;2841851211019804. doi: 10.1177/02841851211019804. Epub 2021 May 30. PMID: 34056917.
Copy Download .nbib Format: NLM
Predictive factors for the duration until return to work after surgery for work-related rotator cuff syndrome: A prospective study of 92 workers.

American journal of industrial medicine

Pichené-Houard A, Paysant J, Claudon L, Paris N, Michel B, Jacquot A, Martinet N, Sirveaux F, Wild P.
PMID: 34541681
Am J Ind Med. 2021 Dec;64(12):1028-1039. doi: 10.1002/ajim.23293. Epub 2021 Sep 19.

BACKGROUND: Return to work (RTW) after surgery for a work-related rotator cuff disorder (WRRCD) is often difficult. The study's purpose was to identify preoperative factors predicting RTW.METHODS: Ninety-two workers with a WRRCD were identified by four surgeons. Before surgery,...

Cite
Pichené-Houard A, Paysant J, Claudon L, et al. Predictive factors for the duration until return to work after surgery for work-related rotator cuff syndrome: A prospective study of 92 workers. Am J Ind Med. 2021;64(12):1028-1039doi: 10.1002/ajim.23293.
Pichené-Houard, A., Paysant, J., Claudon, L., Paris, N., Michel, B., Jacquot, A., Martinet, N., Sirveaux, F., & Wild, P. (2021). Predictive factors for the duration until return to work after surgery for work-related rotator cuff syndrome: A prospective study of 92 workers. American journal of industrial medicine, 64(12), 1028-1039. https://doi.org/10.1002/ajim.23293
Pichené-Houard, Anne, et al. "Predictive factors for the duration until return to work after surgery for work-related rotator cuff syndrome: A prospective study of 92 workers." American journal of industrial medicine vol. 64,12 (2021): 1028-1039. doi: https://doi.org/10.1002/ajim.23293
Pichené-Houard A, Paysant J, Claudon L, Paris N, Michel B, Jacquot A, Martinet N, Sirveaux F, Wild P. Predictive factors for the duration until return to work after surgery for work-related rotator cuff syndrome: A prospective study of 92 workers. Am J Ind Med. 2021 Dec;64(12):1028-1039. doi: 10.1002/ajim.23293. Epub 2021 Sep 19. PMID: 34541681.
Copy Download .nbib Format: NLM
Emergent open conversion for stent-graft deployment failure in a ruptured thoracic aneurysm.

Journal of vascular surgery cases and innovative techniques

Kohler C, Wyss TR, Mertineit N, Makaloski V, Schmidli J.
PMID: 33748558
J Vasc Surg Cases Innov Tech. 2020 Nov 05;7(1):180-182. doi: 10.1016/j.jvscit.2020.10.017. eCollection 2021 Mar.

Thoracic endovascular aortic repair (TEVAR) is the standard of care for ruptured thoracic aortic aneurysms. A 92-year-old man had presented in stable condition but with acute severe back pain. Computed tomography revealed a ruptured thoracic aortic aneurysm. TEVAR (Valiant;...

Cite
Kohler C, Wyss TR, Mertineit N, et al. Emergent open conversion for stent-graft deployment failure in a ruptured thoracic aneurysm. J Vasc Surg Cases Innov Tech. 2020;7(1):180-182doi: 10.1016/j.jvscit.2020.10.017.
Kohler, C., Wyss, T. R., Mertineit, N., Makaloski, V., & Schmidli, J. (2021). Emergent open conversion for stent-graft deployment failure in a ruptured thoracic aneurysm. Journal of vascular surgery cases and innovative techniques, 7(1), 180-182. https://doi.org/10.1016/j.jvscit.2020.10.017
Kohler, Corinne, et al. "Emergent open conversion for stent-graft deployment failure in a ruptured thoracic aneurysm." Journal of vascular surgery cases and innovative techniques vol. 7,1 (2021): 180-182. doi: https://doi.org/10.1016/j.jvscit.2020.10.017
Kohler C, Wyss TR, Mertineit N, Makaloski V, Schmidli J. Emergent open conversion for stent-graft deployment failure in a ruptured thoracic aneurysm. J Vasc Surg Cases Innov Tech. 2020 Nov 05;7(1):180-182. doi: 10.1016/j.jvscit.2020.10.017. eCollection 2021 Mar. PMID: 33748558; PMCID: PMC7966836.
Copy Download .nbib Format: NLM
Imidazo[2,1-.

ACS medicinal chemistry letters

Christodoulou MS, Dapiaggi F, Ghiringhelli F, Pieraccini S, Sironi M, Lucafò M, Curci D, Decorti G, Stocco G, Chirumamilla CS, Vanden Berghe W, Balaguer P, Michel BY, Burger A, Beccalli EM, Passarella D, Martinet N.
PMID: 29670697
ACS Med Chem Lett. 2018 Feb 26;9(4):339-344. doi: 10.1021/acsmedchemlett.7b00527. eCollection 2018 Apr 12.

Glucocorticoid receptor (GCR) transactivation reporter gene assays were used as an initial high-throughput screening on a diversified library of 1200 compounds for their evaluation as GCR antagonists. A class of imidazo[2,1-

Cite
Christodoulou MS, Dapiaggi F, Ghiringhelli F, et al. Imidazo[2,1-. ACS Med Chem Lett. 2018;9(4):339-344doi: 10.1021/acsmedchemlett.7b00527.
Christodoulou, M. S., Dapiaggi, F., Ghiringhelli, F., Pieraccini, S., Sironi, M., Lucafò, M., Curci, D., Decorti, G., Stocco, G., Chirumamilla, C. S., Vanden Berghe, W., Balaguer, P., Michel, B. Y., Burger, A., Beccalli, E. M., Passarella, D., & Martinet, N. (2018). Imidazo[2,1-. ACS medicinal chemistry letters, 9(4), 339-344. https://doi.org/10.1021/acsmedchemlett.7b00527
Christodoulou, Michael S, et al. "Imidazo[2,1-." ACS medicinal chemistry letters vol. 9,4 (2018): 339-344. doi: https://doi.org/10.1021/acsmedchemlett.7b00527
Christodoulou MS, Dapiaggi F, Ghiringhelli F, Pieraccini S, Sironi M, Lucafò M, Curci D, Decorti G, Stocco G, Chirumamilla CS, Vanden Berghe W, Balaguer P, Michel BY, Burger A, Beccalli EM, Passarella D, Martinet N. Imidazo[2,1-. ACS Med Chem Lett. 2018 Feb 26;9(4):339-344. doi: 10.1021/acsmedchemlett.7b00527. eCollection 2018 Apr 12. PMID: 29670697; PMCID: PMC5900336.
Copy Download .nbib Format: NLM
Interpreting clinical assays for histone deacetylase inhibitors.

Cancer management and research

Martinet N, Bertrand P.
PMID: 21625397
Cancer Manag Res. 2011;3:117-41. doi: 10.2147/CMR.S9661. Epub 2011 May 09.

As opposed to genetics, dealing with gene expressions by direct DNA sequence modifications, the term epigenetics applies to all the external influences that target the chromatin structure of cells with impact on gene expression unrelated to the sequence coding...

Cite
Martinet N, Bertrand P. Interpreting clinical assays for histone deacetylase inhibitors. Cancer Manag Res. 2011;3:117-41doi: 10.2147/CMR.S9661.
Martinet, N., & Bertrand, P. (2011). Interpreting clinical assays for histone deacetylase inhibitors. Cancer management and research, 3117-41. https://doi.org/10.2147/CMR.S9661
Martinet, Nadine, and Bertrand, Philippe. "Interpreting clinical assays for histone deacetylase inhibitors." Cancer management and research vol. 3 (2011): 117-41. doi: https://doi.org/10.2147/CMR.S9661
Martinet N, Bertrand P. Interpreting clinical assays for histone deacetylase inhibitors. Cancer Manag Res. 2011;3:117-41. doi: 10.2147/CMR.S9661. Epub 2011 May 09. PMID: 21625397; PMCID: PMC3101110.
Copy Download .nbib Format: NLM
Catheter Directed Thrombectomy Under Temporary Catheter Based Filter Protection in Renal Vein Thrombosis and Contraindication to Anticoagulation.

EJVES vascular forum

Haine A, Rosenov A, Mertineit N, Baumgartner I, Schindewolf M.
PMID: 33089223
EJVES Vasc Forum. 2020 Sep 19;49:16-19. doi: 10.1016/j.ejvsvf.2020.09.001. eCollection 2020.

INTRODUCTION: A 55 year old man who suffered from recurrent traumatic multi-organ bleeding presented with deterioration in kidney function and pulmonary embolism caused by a newly diagnosed renal vein thrombosis during hospitalisation.REPORT: Complete clot removal was performed successfully by...

Cite
Haine A, Rosenov A, Mertineit N, et al. Catheter Directed Thrombectomy Under Temporary Catheter Based Filter Protection in Renal Vein Thrombosis and Contraindication to Anticoagulation. EJVES Vasc Forum. 2020;49:16-19doi: 10.1016/j.ejvsvf.2020.09.001.
Haine, A., Rosenov, A., Mertineit, N., Baumgartner, I., & Schindewolf, M. (2020). Catheter Directed Thrombectomy Under Temporary Catheter Based Filter Protection in Renal Vein Thrombosis and Contraindication to Anticoagulation. EJVES vascular forum, 4916-19. https://doi.org/10.1016/j.ejvsvf.2020.09.001
Haine, Axel, et al. "Catheter Directed Thrombectomy Under Temporary Catheter Based Filter Protection in Renal Vein Thrombosis and Contraindication to Anticoagulation." EJVES vascular forum vol. 49 (2020): 16-19. doi: https://doi.org/10.1016/j.ejvsvf.2020.09.001
Haine A, Rosenov A, Mertineit N, Baumgartner I, Schindewolf M. Catheter Directed Thrombectomy Under Temporary Catheter Based Filter Protection in Renal Vein Thrombosis and Contraindication to Anticoagulation. EJVES Vasc Forum. 2020 Sep 19;49:16-19. doi: 10.1016/j.ejvsvf.2020.09.001. eCollection 2020. PMID: 33089223; PMCID: PMC7560707.
Copy Download .nbib Format: NLM
Can We Achieve Intuitive Prosthetic Elbow Control Based on Healthy Upper Limb Motor Strategies?.

Frontiers in neurorobotics

Merad M, de Montalivet É, Touillet A, Martinet N, Roby-Brami A, Jarrassé N.
PMID: 29456499
Front Neurorobot. 2018 Feb 02;12:1. doi: 10.3389/fnbot.2018.00001. eCollection 2018.

Most transhumeral amputees report that their prosthetic device lacks functionality, citing the control strategy as a major limitation. Indeed, they are required to control several degrees of freedom with muscle groups primarily used for elbow actuation. As a result,...

Cite
Merad M, de Montalivet É, Touillet A, et al. Can We Achieve Intuitive Prosthetic Elbow Control Based on Healthy Upper Limb Motor Strategies?. Front Neurorobot. 2018;12:1doi: 10.3389/fnbot.2018.00001.
Merad, M., de Montalivet, �. �., Touillet, A., Martinet, N., Roby-Brami, A., & Jarrassé, N. (2018). Can We Achieve Intuitive Prosthetic Elbow Control Based on Healthy Upper Limb Motor Strategies?. Frontiers in neurorobotics, 121. https://doi.org/10.3389/fnbot.2018.00001
Merad, Manelle, et al. "Can We Achieve Intuitive Prosthetic Elbow Control Based on Healthy Upper Limb Motor Strategies?." Frontiers in neurorobotics vol. 12 (2018): 1. doi: https://doi.org/10.3389/fnbot.2018.00001
Merad M, de Montalivet É, Touillet A, Martinet N, Roby-Brami A, Jarrassé N. Can We Achieve Intuitive Prosthetic Elbow Control Based on Healthy Upper Limb Motor Strategies?. Front Neurorobot. 2018 Feb 02;12:1. doi: 10.3389/fnbot.2018.00001. eCollection 2018. PMID: 29456499; PMCID: PMC5801430.
Copy Download .nbib Format: NLM
Showing 1 to 8 of 8 entries